#OraklOncology, a French #TechBio company using AI and real patient biology to predict how #cancer drugs will perform in clinical trials, today announced a €30 ...
#OraklOncology, a French #TechBio company using AI and real patient biology to predict how #cancer drugs will perform in clinical trials, today announced a €30 million #SeriesA 🇫🇷 🧬